Alterity Therapeutics (ATHE) Live Share Price, Invest From India

Alterity Therapeutics Stock Performance

as on October 24, 2026 at 6:23 am IST

Day's Low
Day's High
$2.04
Day's Price Range
$2.43
$2.08
1.92%
Downside
16.83%
Upside
52 Week's Low
52 Week's High
$2.09
52-Week Price Range
$5.89
$2.08
-0.43%
Downside
183.28%
Upside

Alterity Therapeutics share price movements today

Previous Close: $2.15
Open: $2.16
Volume: 137.5K
Market Cap: $43.5M
Day's Low - High: $2.04 - $2.43
52 Week Low - High: $2.09 - $5.89

Alterity Therapeutics Historical Returns

1 Month Return: -39.44 %
3 Month Return: -54.16 %
1 Year Return: -53.26 %
3 Year Return: -20.37 %
5 Year Return: -82.8 %

Alterity Therapeutics Stock Fundamentals & Key Indicators

Check Alterity Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$43.5M

EPS (TTM)

-1.32

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.31

Industry PE ratio

-6.30

PEG Ratio

0.13

EBITDA

-28.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-48.25%

Alterity Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alterity Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Alterity Therapeutics	Buy	$43.5M	-82.80%	-2.31	0.00%	0.00%
Moderna	Neutral	$98.1B	-37.95%	-30.80	-12.57%	0.00%
BeOne Medicines	StrongBuy	$44.0B	NA	27.47	87.82%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.9B	191.61%	30.28	86.04%	0.00%
Regeneron	Buy	$83.1B	43.11%	19.24	84.86%	0.46%

Stock Returns calculator for Alterity Therapeutics Stock including INR - Dollar returns

The Alterity Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Alterity Therapeutics investment value today

Current value as on today

₹48,906

Returns

-₹51,094

(-51.09%)

Returns from Alterity Therapeutics Stock

-₹54,783 (-54.78%)

Dollar Impact

₹3,689 (+3.69%)

Analyst Recommendation on Alterity Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Alterity Therapeutics. Average target price of $13

Alterity Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Alterity Therapeutics.

Current Price

$2.08

Analyzed by

2 Analysts

High

$16

Low

$10

Alterity Therapeutics target price $0, a slight upside of 0% compared to current price of $2.08. According to 2 analysts rating.

Indian Investors' Interest in Alterity Therapeutics Stock

Search interest for Alterity Therapeutics Stock has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 24, 2026 to October 24, 2026

Change:-27% versus previous 30 day period

Alterity Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2021	Jun 2022	Dec 2022	Jun 2023	Dec 2023	Jun 2024	Dec 2024	Jun 2025	Dec 2025	Jun 2026
Total Revenue	2	2	2	1	1	2	1	3	-	-
Gross Profit	2	2	2	1	1	2	1	3	0	0
Operating Income	-10	-10	-10	-7	-4	-12	-7	-7	-12	-15
EBITDA	-8	-8	-10	-7	-8	-14	-7	-7	-12	-15
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-8	-10	-7	-4	-14	-8	-4	-12	-14
Income Tax Expense	-2	-2	-2	-1	-1	-2	-1	0	-2	0
Net Income	-6	-6	-8	-5	-6	-12	-7	-4	-9	-13
Net Profit Margin	98.66%	99.18%	97.90%	96.58%	96.11%	96.53%	96.04%	98.33%	0.00%	0.00%

Alterity Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025	Jun 2026
Total Revenue	0	0	0	-	4	5	3	4	5	-
Gross Profit	0	0	0	0	3	4	3	3	5	0
Operating Income	-6	-7	-12	-10	-15	-15	-14	-19	-14	-27
EBITDA	-6	-11	-12	-13	-15	-17	-14	-19	-14	-27
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-8	-12	-10	-15	-12	-13	-19	-12	-26
Income Tax Expense	0	0	0	0	-3	0	0	0	0	-3
Net Income	-7	-8	-11	-10	-15	-12	-13	-19	-12	-22
Net Profit Margin	83.89%	89.16%	72.64%	0.00%	91.70%	92.88%	92.72%	94.67%	97.66%	0.00%

Alterity Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Dec 2021	Jun 2022	Dec 2022	Jun 2023	Dec 2023	Jun 2024	Dec 2024	Jun 2025	Dec 2025	Jun 2026
Net Income	-6	-6	-8	-3	-4	-12	-7	-3	-9	-13
Operating Cash Flow	-8	0	-5	-10	-4	-8	-8	-2	-10	-12
Investing Cash Flow	0	0	0	0	0	0	-	-7	7	0
Financing Cash Flow	0	0	0	0	0	8	0	25	18	1
Change in Cash	-4	2	-6	-25	-4	0	-4	15	16	-10

Alterity Therapeutics Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025	Jun 2026
Net Income	-7	-8	-12	-10	-15	-12	-13	-19	-12	-22
Operating Cash Flow	-5	-6	-13	-9	-17	-12	-20	-12	-11	-22
Investing Cash Flow	0	0	0	0	0	0	0	0	-7	7
Financing Cash Flow	0	0	12	3	36	16	0	9	39	18
Change in Cash	-6	-6	0	-5	18	6	-19	-3	20	5

Global Institutional Holdings in Alterity Therapeutics

Check out the Institutions with significant holdings in Alterity Therapeutics.

Funds	Holdings
Fidelity Concord Street Trust	0.01%

Insights on Alterity Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 802.96K → 3.83M (in $), with an average increase of 54.1% per quarter
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 178.1%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 725.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ATHE stock has moved down by -17.9%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -4.97M → -13.97M (in $), with an average decrease of 68.9% per quarter

About Alterity Therapeutics

Alterity Therapeutics Limited, an Australian biopharmaceutical firm, focuses on the discovery and development of novel drug treatments for various neurological disorders, such as Alzheimer's, Huntington's, and Parkinson's diseases. Its prominent experimental therapy, ATH434, has completed Phase I clinical trials targeting Parkinson's disease. The company is also advancing PBT2, a compound that has successfully undergone Phase IIa clinical testing for Alzheimer's disease. Established in 1997, the entity was formerly known as Prana Biotechnology Limited before rebranding to Alterity Therapeutics Limited in April 2019, and its main operations are based in Melbourne, Australia.

Organisation	Alterity Therapeutics
Headquarters	500 Collins Street, Melbourne, VIC, 3000, AU
Industry	Biotechnology
CEO	David A. Stamler

Key Management of Alterity Therapeutics

Name	Title
Dr. David A. Stamler M.D.	CEO, MD & Director
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.	CFO & Company Secretary
Dr. Rudolph Emile Tanzi Ph.D.	Chief Scientific Advisor and Member of Research & Development Advisory Board
Dr. Steven D. Targum M.D.	Chief Medical Advisor
Dr. Robert Cherny	Head of Research

FAQs

What is Alterity Therapeutics share price today?

Alterity Therapeutics share price today is $2.08 as on October 24, 2026 at 12:53 am IST. Alterity Therapeutics share today touched a day high of $2.43 and a low of $2.04.

What is the 52 week high and 52 week low for Alterity Therapeutics share?

Alterity Therapeutics share touched a 52 week high of $5.89 on July 6, 2026 and a 52 week low of $2.09 on October 22, 2026. Alterity Therapeutics stock price today i.e. October 24, 2026 at 12:53 am IST is trending at $2.08,which is 64.70% down from its 52 week high and -0.43% up from its 52 week low.

What is Alterity Therapeutics's market capitalisation today?

Alterity Therapeutics market capitalisation is $0.00T as on October 24, 2026 at 12:53 am IST.

How to invest in Alterity Therapeutics Stock (ATHE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alterity Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Alterity Therapeutics Stock (ATHE) from India?

Indian investors can start investing in Alterity Therapeutics (ATHE) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 12:56 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Alterity Therapeutics stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 12:56 am IST). Based on Alterity Therapeutics share’s latest price of $2.08 as on October 24, 2026 at 12:53 am IST, you will get 4.8077 shares of Alterity Therapeutics. Learn more about fractional shares .

What are the returns that Alterity Therapeutics has given to Indian investors in the last 5 years?

Alterity Therapeutics stock has given -82.8% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?